This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scherrer, U. Articles by Brunner, H. R. Search for Related Content PubMed PubMed Citation Articles by Scherrer, U. Articles by Brunner, H. R.

Circulation, Vol 83, 552-558, Copyright © 1991 by American Heart Association

ARTICLES

Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium

U Scherrer, J Nussberger, S Torriani, B Waeber, R Darioli, JR Hofstetter and HR Brunner
Division of Hypertension, C.H.U.V., Lausanne, Switzerland.

Although platelet cytosolic calcium has been shown to decrease during pharmacological treatment of hypertension, there is no evidence that cytosolic calcium also falls during a nonpharmacological reduction in blood pressure. To provide such evidence, we examined prospectively the relation between platelet cytosolic calcium and ambulatory blood pressure during weight reduction in moderately overweight (body mass index [BMI] greater than 25), mildly hypertensive individuals. The experimental group (responders: BMI reduction greater than 5%) consisted of 19 patients who lost 8.5 +/- 2.9 kg (mean +/- SD, p less than 0.05) during a 10-week hypocaloric diet, whereas the control group (nonresponders: BMI reduction less than 5%) consisted of 12 patients who showed no relevant change in body weight (-2.0 +/- 1.3 kg) during the same period of time. The moderate weight loss of the responders decreased blood pressure by 14/5 mm Hg (p less than 0.05), as measured by ambulatory monitoring, which renders a placebo effect unlikely. This nonpharmacological reduction in blood pressure was accompanied by a proportional 11% decrease (p less than 0.05) in platelet cytosolic calcium and also by significant (p less than 0.05) decreases in plasma catecholamines and serum cholesterol. These findings establish the concept of a nonpharmacological reduction in free cytosolic platelet calcium in humans and add further evidence suggesting a link between intracellular calcium homeostasis and blood pressure regulation.

This article has been cited by other articles:

				M. L. G. Correia, D. A. Morgan, W. I. Sivitz, A. L. Mark, and W. G. Haynes Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure Hypertension, March 1, 2001; 37(3): 936 - 942. [Abstract] [Full Text] [PDF]

				U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text]

				R. H. Eckel Obesity and Heart Disease : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, November 4, 1997; 96(9): 3248 - 3250. [Full Text]

				A. Fujinishi, K. Takahara, C. Ohba, Y. Nakashima, A. Kuroiwa, and K. Takahara Effects of Nisoldipine on Cytosolic Calcium, Platelet Aggregation, and Coagulation/Fibrinolysis in Patients with Coronary Artery Disease Angiology, June 1, 1997; 48(6): 515 - 521. [Abstract] [PDF]